GLOW Blend
Also known as GHK-Cu + BPC-157 + TB-500
Aesthetic/repair blend
A three-peptide blend combining dermal remodeling with systemic repair signaling.
How it works
The GLOW blend combines GHK-Cu, BPC-157, and TB-500 in a single formulation, pairing dermal gene-expression signaling with systemic tissue repair pathways. The intent behind combining these three is to address skin quality and underlying tissue repair together rather than as separate research targets.
GHK-Cu contributes copper-dependent gene expression changes that favor collagen and elastin synthesis in skin tissue. BPC-157 adds VEGF-driven angiogenesis, supporting blood vessel growth into repairing tissue, while TB-500 contributes actin-binding cell migration signaling that supports cytoskeletal remodeling and repair cell recruitment.
Because each component has an established individual research record, the blend's proposed mechanism is inferred from combining those pathways. Dedicated trials studying the three-peptide combination as a single unit have not been published.
What research has shown
Evidence is drawn from the individual components; combination trials are not published.
Reported ranges in the literature
Low end
Low-end reconstituted split (≈0.5 mg total daily)
Optimal
≈1 mg total daily
High end
≈1.5 to 2 mg total daily, short blocks
Frequency reported in the literature: Daily, 4 to 8 week blocks
Frequently asked questions
What is the GLOW blend?
GLOW is a combination of GHK-Cu, BPC-157, and TB-500, studied for pairing dermal remodeling signaling with systemic tissue repair pathways.
How does GLOW differ from KLOW?
KLOW contains the same three peptides as GLOW plus KPV, an alpha-MSH fragment studied for anti-inflammatory signaling, extending the blend's profile toward inflammation resolution.
What does the research show?
Evidence is drawn from the individual components: GHK-Cu's dermal gene-expression studies, and BPC-157 and TB-500's tissue repair literature. Combination-specific trials are not published.
How is the GLOW blend stored?
As a lyophilized combination product, it should be kept refrigerated or frozen before reconstitution, then refrigerated with a defined use window afterward.
How long are research blocks typically?
Published protocols for the individual components suggest daily dosing over 4 to 8 week blocks.
Related compounds
Further reading
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.